ID
31680
Description
TIght COntrol of Psoriatic Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01106079
Link
https://clinicaltrials.gov/show/NCT01106079
Keywords
Versions (1)
- 9/20/18 9/20/18 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
September 20, 2018
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Psoriatic Arthritis NCT01106079
Eligibility Psoriatic Arthritis NCT01106079
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Prior Therapy Arthropathy | Antirheumatic Drugs, Disease-Modifying | Methotrexate | Sulfasalazine | leflunomide
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1514463
- UMLS CUI [1,2]
- C0022408
- UMLS CUI [2]
- C0242708
- UMLS CUI [3]
- C0025677
- UMLS CUI [4]
- C0036078
- UMLS CUI [5]
- C0063041
Description
Pregnancy | Breast Feeding | Pregnancy, Planned
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
- UMLS CUI [3]
- C0032992
Description
Investigational New Drugs
Data type
boolean
Alias
- UMLS CUI [1]
- C0013230
Similar models
Eligibility Psoriatic Arthritis NCT01106079
- StudyEvent: Eligibility
C0872146 (UMLS CUI [1,2])
C0451530 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0451521 (UMLS CUI [2,2])
C1282952 (UMLS CUI [3])
C2348563 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2])
C0700589 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C0031843 (UMLS CUI [1,2])
C0151904 (UMLS CUI [2])
C0022408 (UMLS CUI [1,2])
C0242708 (UMLS CUI [2])
C0025677 (UMLS CUI [3])
C0036078 (UMLS CUI [4])
C0063041 (UMLS CUI [5])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])